Combining blood gas invasive and non-invasive monitoring for the best care of our neonates
October 8, 2015
Webinar presented by Dr. Kaare E. Lundstrøm, Pediatric emergency and intensive care unit, Rigshospitalet, Denmark
Note: You can now join Webex Event Center from iPhones, iPads, and Android devices. Visit the Apple Store or Google Play to install the latest free app on your device.
About this webinar
The survival rate of critically ill newborns has increased during the last few decades, especially for extremely preterm infants. However, overall morbidity in surviving newborns is still high in many centers. With this increasing survival rate, it is now clear that many survivors without diagnosed major brain injuries like cerebral hemorrhages or periventricular leucomalacia will suffer from behavioral problems and learning disabilities later in life. This is likely to be a result of minor brain injuries in the neonatal period due to antenatal injuries. Other factors like nutrition may also play a significant role.
This webinar will focus on how the risk of brain damage in the sick newborn is minimized by combining the invasive and the non-invasive monitoring of blood gases.
Information on blood gas status in the critically ill newborn is necessary to provide good clinical care. Information on the oxygen status is essential, as both hypoxemia and hyperoxemia can cause brain damage. Additionally, the physiological changes in sick newborns and infants often occur within minutes, especially changes in pCO2 in ventilated newborns. For this reason, even frequent intermittent monitoring of the blood gas status in the unstable, ventilated newborn can result in undetected or delayed diagnosed changes in the blood gas status, which will increase the risk of brain damage. The continuous monitoring of pCO2 is in the ventilated newborn is at least as important as the monitoring of oxygen status.
This webinar will provide scientific evidence of the benefit of transcutaneous monitoring as well as offer clinical examples of its use.
Who should attend?
- Physicians
- Nurses
- Respiratory Therapists
- Midwives
- Point of care coordinators/supervisors/managers
- Quality managers
- Laboratorians
- Biomedical Scientists
- Clinical biochemists
Continuing education - US participants
- One PACE® credit-hour will be provided for each session. Each session is approved for 1 Florida CE credit.
- Florida Board of Clinical Laboratory Personnel approved number:
50-12563 - Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.
International participants
A Certificate of Attendance will be available for all sessions for international participants to submit to their appropriate accrediting agencies
Radiometer is using Microsoft AZURE Active Directory to authenticate users
Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.
If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.
Key benefits
- Allow the use of existing Active Directory credentials
- Single-sign on experience
- Use same credentials to access future services
Request access
You will receive an invitation to access our services via e-mail when your request has been approved.
When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.
Effective Date January 20th, 2023 (last updated January 20th, 2023)
ABOUT THIS POLICY
Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.
“Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.
The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.
SCOPE
This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.
There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.
We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.
Read more